Occult hepatitis B virus in liver tissue of individuals without hepatic disease

被引:180
作者
Raimondo, Giovanni [1 ]
Navarra, Giuseppe [2 ]
Mondello, Stefania [1 ]
Costantino, Lucy [1 ]
Colloredo, Guido [3 ]
Cucinotta, Eugenio [4 ]
Di Vita, Gaetano [5 ]
Scisca, Claudio [4 ]
Squadrito, Giovanni [1 ]
Pollicino, Teresa [1 ]
机构
[1] Messina Univ Hosp, Dept Internal Med, Unit Clin & Mol Hepatol, I-98124 Messina, Italy
[2] Messina Univ Hosp, Dept Surg Sci, Messina, Italy
[3] Seriate Hosp, Liver Unit, Bergamo, Italy
[4] Messina Univ Hosp, Dept Human Pathol, Messina, Italy
[5] Palermo Univ Hosp, Dept Surg & Oncol Sci, Palermo, Italy
关键词
occult HBV; HBV DNA; normal liver; anti-HBc; HBV-seronegative;
D O I
10.1016/j.jhep.2008.01.023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: While many data are available concerning occult hepatitis B virus (HBV) infection in patients with hepatic disorders, there is little information about this cryptic infection in individuals without liver disease. The aim of this study was to investigate the prevalence of occult HBV in the general population by examining liver specimens from a large series of HBV-surface-antigen negative individuals with no clinical and biochemical evidence of liver disease. Methods: The presence of HBV DNA was evaluated by testing, through polymerase chain reaction techniques, DNA extracts from 98 liver-disease-free individuals who underwent liver resection or needle biopsy during abdominal surgery. Sixteen of them were anti-HBV-core antigen (anti-HBc) positive and 82 were HBV serum-marker negative. All patients were negative for antibody to hepatitis C virus. Results:Occult HBV infection was revealed in 16 of the 98 cases (16.3%). In particular, 10/16 anti-HBc positive (62.5%) versus 6/82 (7.3%) HBV-seronegative individuals were occult carriers (p < 0.0001). Conclusions: This study revealed that about 1/6 of the Italian general population might be carriers of occult HBV infection, and this condition is significantly associated with the anti-HBc positive status. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:743 / 746
页数:4
相关论文
共 24 条
[1]   Occult hepatitis B virus infection: implications in transfusion [J].
Allain, JP .
VOX SANGUINIS, 2004, 86 (02) :83-91
[2]   Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"? [J].
Bréchot, C ;
Thiers, V ;
Kremsdorf, D ;
Nalpas, B ;
Pol, S ;
Paterlini-Bréchot, P .
HEPATOLOGY, 2001, 34 (01) :194-203
[3]   Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].
Cacciola, I ;
Pollicino, T ;
Squadrito, G ;
Cerenzia, G ;
Orlando, ME ;
Raimondo, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26
[4]   OCCULT HEPATITIS-B VIRUS AS SOURCE OF INFECTION IN LIVER-TRANSPLANT RECIPIENTS [J].
CHAZOUILLERES, O ;
MAMISH, D ;
KIM, M ;
CAREY, K ;
FERRELL, L ;
ROBERTS, JP ;
ASCHER, NL ;
WRIGHT, TL .
LANCET, 1994, 343 (8890) :142-146
[5]   Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen [J].
Dickson, RC ;
Everhart, JE ;
Lake, JR ;
Wei, YL ;
Seaberg, EC ;
Wiesner, RH ;
Zetterman, RK ;
Pruett, TL ;
Ishitani, MB ;
Hoofnagle, JH ;
Detre, KM ;
Demetris, AJ ;
Lombardero, M ;
Seaberg, E ;
Lawlor, S ;
Fitzgerald, S ;
Haber, J ;
Swanson, GL ;
Wiesner, R ;
Krom, R ;
Porayko, MK ;
Schwerman, L ;
Groettum, C ;
Shaw, B ;
Taylor, K ;
Ascher, N ;
Lake, J ;
BremerKamp, C ;
Everhart, J ;
Shores, S ;
Broccoli, A ;
Hausman, G ;
Shepard, B ;
Carrol, N ;
McGory, R ;
Stevenson, WC ;
McCullough, C ;
Caldwell, S .
GASTROENTEROLOGY, 1997, 113 (05) :1668-1674
[6]   HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity [J].
Gerlich, Wolfram H. ;
Wagner, Franz F. ;
Chudy, Michael ;
Harritshoj, Lene Holm ;
Lattermann, Anisette ;
Wienzek, Sandra ;
Glebe, Dieter ;
Saniewski, Mona ;
Schuettler, Christian G. ;
Wend, Ulrike C. ;
Willems, Wulf R. ;
Bauerfeind, Ursula ;
Jork, Christine ;
Bein, Gregor ;
Platz, Per ;
Ullum, Henrik ;
Dickmeiss, Ebbe .
JOURNAL OF MEDICAL VIROLOGY, 2007, 79 :S32-S36
[7]   Hepatitis B virus reactivation and alemtuzumab therapy [J].
Iannitto, E ;
Minardi, V ;
Calvaruso, G ;
Mulè, A ;
Ammatuna, E ;
Trapani, RD ;
Ferraro, D ;
Abbadessa, V ;
Craxí, A ;
Stefano, RD .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (03) :254-258
[8]   Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies [J].
Kawatani, T ;
Suou, T ;
Tajima, F ;
Ishiga, K ;
Omura, H ;
Endo, A ;
Ohmura, H ;
Ikuta, Y ;
Idobe, Y ;
Kawasaki, H .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 67 (01) :45-50
[9]  
Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt
[10]  
249::AID-JMV3&gt